Antidepressant activity of aqueous extracts of Curcuma longa in mice

Journal of Ethnopharmacology

Volumn 83, Issue 1-2, 2002, Pages 161-165

  Yu, Z F ^a   Kong, L D ^a   Chen, Y ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Antidepressant activity; Curcuma longa; Immobility; MAO A; MAO B

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANTIDEPRESSANT AGENT; CURCUMA LONGA EXTRACT; FLUOXETINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; IN VIVO STUDY; LOCOMOTION; MALE; MOUSE; NONHUMAN; SWIMMING;

ADMINISTRATION, ORAL; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; CURCUMA; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; MALE; MICE; MICE, INBRED ICR; MITOCHONDRIA; MONOAMINE OXIDASE; MOTOR ACTIVITY; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 0036876318     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-8741(02)00211-8     Document Type: Article

References (24)

1. Antony S., Kuttan R., Kuttan G. Immunomodulatory activity of curcumin. Immunological Investigations. 28:1999;291-303.
2. Archer J. Tests for emotionality in rats and mice: a review. Animal Behavior. 21:1973;205-235.
3. Butterweck V., Petereit F., Winterhoff H., Nahrstedt A. Solubilized hypericin and pseudohypericin from Hypercum perforatum exert antidepressant activity in the forced swimming test. Planta Medica. 64:1998;291-294.
4. Charles, M., McEwen, J., 1977. In: Tabor H., Tabor C.W., (Eds.), Methods in Enzymology, XVIIB, New York and London, Academic Press, pp. 692-698.
5. Gupta B., Ghosh B. Curcuma longa inhibits TNF-α induced expression of adhesion molecules on human umbilical vein endothelial cells. International Journal of Immunopharmacology. 21:1999;745-757.
6. Kamal-Eldin A., Frank J., Razdan A., Tengblad S., Basu S., Vessby B. Effects of dietary phenolic compounds on tocopherol, cholesterol, and fatty acids in rats. Lipids. 35:2000;427-435.
7. Kang B.Y., Song Y.J., Kim K.M., Choe Y.K., Hwang S.Y., Kim T.S. Curcumin inhibits Th1 cytokine profile in CD4±T cells by suppressing interleukin-12 production in macrophages. British Journal of Pharmacology. 128:1999;380-384.
8. Khanna N.M. Turmeric - nature's precious gift. Current Science. 76:1999;1351-1356.
9. Knoll J. History of deprenyl - the first selective inhibitor of monoamine oxidase type B. Voprosy Meditsinskoi Khimii. 43:1997;482-493.
10. Kong L.D., Tan R.X., Woo A.Y., Cheng C.H.K. Inhibition of rat brain monoamine oxidase activities by psoralen and isopsoralen: implications for the treatment of affective disorders. Pharmacology and Toxicology. 88:2001;75-80.
11. Kong L.D., Cheng C.H.K., Tan R.X. Monoamine oxidase inhibitiors from rhizoma of Coptis chinensis. Planta Medica. 67:2001;74-76.
12. Licinio J., Wong M.L. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Molecular Psychiatry. 4:1999;317-327.
13. Lowry O.H., Rosebrough N.J., Far,r A.L., Randall R.J. Protein measurement with folin phenol reagent. The Journal of Biological Chemistry. 193:1951;265-275.
14. Luo L., Wang J.N., Kong L.D., Jiang Q.G., Tan R.X. Antidepressant effects of Banxia Houpu decoction, a traditional Chinese medicinal empirical formula. Journal of Ethnopharmacology. 73:2000;277-281.
15. 6 cells. Planta Medica. 64:1998;603-607.
16. Mendlovic S., Doron A., Eilat E. Short note: can depressive patients exploit the immune system for suicide. Medical Hypotheses. 49:1997;445-446.
17. Mendelovic S., Doron A., Shoenfeld Y. Depression and the immune system. Harefuah. 136:1999;88-91.
18. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressant. Archives Internationales de Pharmacodynamic et de Theroapie. 229:1977;327-336.
19. Porsolt R.D., Le Pichon M., Jalfre M., Chatterjee S.S. Depression: a new animal model sensitive to antidepressant treatments. Nature. 266:1977;730-732.
20. Porsolt, R.D., Anton, G., Blavet, N., Jalfre M., 1978. Behavioral despair in rats: a new model sensitive to antidepressant treatments. European Journal of Pharmacology 1978, 47, 379-391.
21. Schurr A., Livne A. Different inhibition of mitochondrial monoamine oxidase from brain by hashish components. Biochemical Pharmacology. 25:1976;1201-1203.
22. Stano J., Grancai D., Neubert K., Kresanek J. Curcumin as a potential antioxidant agent. Ceska a Slovenska Farmacie. 49:2000;168-170.
23. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening ahtidepressants in mice. Psychopharmacology (Berlin). 85:1985;367-370.
24. Wouters J. Structural aspects of monoamine oxidase and its reversible inhibition. Current Medicinal Chemistry. 5:1998;137-162.